These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 16911906)

  • 1. Patient selection for primary prevention ICDs--are eps shocking patients into consent?
    Saxon LA
    J Card Fail; 2006 Aug; 12(6):413-5. PubMed ID: 16911906
    [No Abstract]   [Full Text] [Related]  

  • 2. Selecting patients for discussion of the ICD as primary prevention for sudden death in heart failure.
    Stevenson LW; Desai AS
    J Card Fail; 2006 Aug; 12(6):407-12. PubMed ID: 16911905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implantable cardioverter-defibrillators save lives. Why are only 15-20 percent of those who might benefit offered these souped-up pacemakers?
    Health News; 2005 Aug; 11(8):5-6. PubMed ID: 16184639
    [No Abstract]   [Full Text] [Related]  

  • 4. Defibrillators decrease/increase risk of death.
    Health News; 2006 Oct; 12(10):13. PubMed ID: 17165186
    [No Abstract]   [Full Text] [Related]  

  • 5. Electrophysiologic testing and the use of devices in heart failure.
    Heart Failure Society Of America
    J Card Fail; 2006 Feb; 12(1):e70-5. PubMed ID: 16500573
    [No Abstract]   [Full Text] [Related]  

  • 6. Sex-based differences in cardiac resynchronization therapy and implantable cardioverter defibrillator therapies: effectiveness and use.
    Yarnoz MJ; Curtis AB
    Cardiol Rev; 2006; 14(6):292-8. PubMed ID: 17053376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The ABCD (Alternans Before Cardioverter Defibrillator) Trial: strategies using T-wave alternans to improve efficiency of sudden cardiac death prevention.
    Costantini O; Hohnloser SH; Kirk MM; Lerman BB; Baker JH; Sethuraman B; Dettmer MM; Rosenbaum DS;
    J Am Coll Cardiol; 2009 Feb; 53(6):471-9. PubMed ID: 19195603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Refining patient selection for primary prevention implantable cardioverter-defibrillator therapy: reeling in a net cast too widely.
    Tung R; Swerdlow CD
    Circulation; 2009 Sep; 120(10):825-7. PubMed ID: 19704090
    [No Abstract]   [Full Text] [Related]  

  • 9. Effectiveness of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death in women with advanced heart failure: a meta-analysis of randomized controlled trials.
    Ghanbari H; Dalloul G; Hasan R; Daccarett M; Saba S; David S; Machado C
    Arch Intern Med; 2009 Sep; 169(16):1500-6. PubMed ID: 19752408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implantation of cardiac defibrillators for primary prevention: a pendulum too far?
    Ferreira SW; Hauptman PJ
    Expert Rev Cardiovasc Ther; 2008 Sep; 6(8):1047-50. PubMed ID: 18793106
    [No Abstract]   [Full Text] [Related]  

  • 11. [Prevention of sudden death with the implantable defibrillator in hypertrophic cardiomyopathy].
    Maron BJ
    Rev Esp Cardiol; 2006 Jun; 59(6):527-30. PubMed ID: 16790193
    [No Abstract]   [Full Text] [Related]  

  • 12. Application of the main implantable cardioverter-defibrillator trials and the 2006 Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death.
    Proclemer A; Ghidina M
    J Cardiovasc Med (Hagerstown); 2007 May; 8(5):320-3. PubMed ID: 17443096
    [No Abstract]   [Full Text] [Related]  

  • 13. Shocking news. overdoing ICDs. They can shock a heart back into rhythm and save a life. But are too many of these heart devices being implanted?
    Harv Health Lett; 2011 Mar; 36(5):1-3. PubMed ID: 21649968
    [No Abstract]   [Full Text] [Related]  

  • 14. Primary prevention of sudden cardiac death using implantable cardioverter defibrillators.
    Ding L; Hua W; Niu H; Chen K; Zhang S
    Europace; 2008 Sep; 10(9):1034-41. PubMed ID: 18559335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The high cost of implantable defibrillators.
    Hlatky MA; Mark DB
    Eur Heart J; 2007 Feb; 28(4):388-91. PubMed ID: 17032689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preventing sudden death: implantable cardioverter-defibrillators in elderly cardiac patients.
    Groeneveld PW
    LDI Issue Brief; 2008; 13(6):1-4. PubMed ID: 18613344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary prevention: a necessity after myocardial infarction with left ventricular dysfunction.
    Valk S; Jordaens L
    Europace; 2009 Apr; 11(4):407-8. PubMed ID: 19279027
    [No Abstract]   [Full Text] [Related]  

  • 18. Incidence and characteristics of appropriate and inappropriate therapies in recipients of ICD implanted for primary prevention of sudden cardiac death.
    Kreuz J; Balta O; Liliegren N; Mellert F; Esmailzadeh B; Nickenig G; Schwab JO
    Pacing Clin Electrophysiol; 2007 Jan; 30 Suppl 1():S125-7. PubMed ID: 17302687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of gender on survival amongst patients with implantable cardioverter defibrillators for primary prevention against sudden cardiac death.
    Henyan NN; White CM; Gillespie EL; Smith K; Coleman CI; Kluger J
    J Intern Med; 2006 Nov; 260(5):467-73. PubMed ID: 17040253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sudden cardiac death: the role of risk stratification.
    Kusmirek SL; Gold MR
    Am Heart J; 2007 Apr; 153(4 Suppl):25-33. PubMed ID: 17394900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.